These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19758804)

  • 21. The long and winding road from the research laboratory to industrial applications of lactic acid bacteria.
    Pedersen MB; Iversen SL; Sørensen KI; Johansen E
    FEMS Microbiol Rev; 2005 Aug; 29(3):611-24. PubMed ID: 15935510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current state-of-the-art in plant-based antibody production systems.
    Donini M; Marusic C
    Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic animals for the production of biological medicines.
    Minor PD
    Dev Biol (Basel); 2004; 118():165-9. PubMed ID: 15645687
    [No Abstract]   [Full Text] [Related]  

  • 24. Rational and systematic protein purification process development: the next generation.
    Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M
    Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent advances in the production of heterologous proteins in filamentous fungi].
    Zhong Y; Wang X; Wang T
    Sheng Wu Gong Cheng Xue Bao; 2008 Apr; 24(4):531-40. PubMed ID: 18616158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of Pseudozyma yeastlike epiphytes for the production of heterologous recombinant proteins.
    Avis TJ; Cheng YL; Zhao YY; Bolduc S; Neveu B; Anguenot R; Labbé C; Belzile F; Bélanger RR
    Appl Microbiol Biotechnol; 2005 Dec; 69(3):304-11. PubMed ID: 15830195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of recombinant proteins by microbes and higher organisms.
    Demain AL; Vaishnav P
    Biotechnol Adv; 2009; 27(3):297-306. PubMed ID: 19500547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in protein glycosylation in Hansenula polymorpha depending on cell culture stage.
    Kim SY; Sohn JH; Pyun YR; Choi ES
    J Microbiol Biotechnol; 2007 Dec; 17(12):1949-54. PubMed ID: 18167441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression, purification, and analyses of glycosylation and disulfide bonds of Stereum purpureum endopolygalacturonase I in Pichia pastoris.
    Ogawa S; Shimizu T; Ohki H; Araya T; Okuno T; Miyairi K
    Protein Expr Purif; 2009 May; 65(1):15-22. PubMed ID: 19174189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developments in biotechnological production of sweet proteins.
    Masuda T; Kitabatake N
    J Biosci Bioeng; 2006 Nov; 102(5):375-89. PubMed ID: 17189164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-processing of biological products: regulatory considerations from the CBER perspective.
    Shacter E
    Dev Biol (Basel); 2003; 113():105-7; discussion 115-6. PubMed ID: 14620859
    [No Abstract]   [Full Text] [Related]  

  • 32. Transgenic chickens as bioreactors for protein-based drugs.
    Lillico SG; McGrew MJ; Sherman A; Sang HM
    Drug Discov Today; 2005 Feb; 10(3):191-6. PubMed ID: 15708533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Going into production.
    Clayton J
    Nature; 2003 Dec; 426(6967):727. PubMed ID: 14668883
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteins of higher fungi--from forest to application.
    Erjavec J; Kos J; Ravnikar M; Dreo T; Sabotič J
    Trends Biotechnol; 2012 May; 30(5):259-73. PubMed ID: 22341093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [GMOs and production of pharmaceutical molecules].
    Faye L; Lerouge P; Gomord V
    Bull Acad Natl Med; 2002; 186(8):1411-25. PubMed ID: 12669360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biosimilar: can we manage biopharmaceutical heterogeneity?].
    Ranieri E
    G Ital Nefrol; 2008; 25(3):275. PubMed ID: 18473296
    [No Abstract]   [Full Text] [Related]  

  • 37. Modern aspects of mushroom culture technology.
    Sánchez C
    Appl Microbiol Biotechnol; 2004 Jun; 64(6):756-62. PubMed ID: 14966664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering the glycosylation of natural products in actinomycetes.
    Salas JA; Méndez C
    Trends Microbiol; 2007 May; 15(5):219-32. PubMed ID: 17412593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Industrial biotechnology for the production of bio-based chemicals--a cradle-to-grave perspective.
    Hatti-Kaul R; Törnvall U; Gustafsson L; Börjesson P
    Trends Biotechnol; 2007 Mar; 25(3):119-24. PubMed ID: 17234288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.